LSB
LakeShore Biopharma
6 hedge funds and large institutions have $1.34M invested in LakeShore Biopharma in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 5 reducing their positions, and 2 closing their positions.
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$486K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $486K | 140,428 | +140,428 | New |
|
2
Fidelity Investments
Boston,
Massachusetts
| $402K | 116,508 | -1,048,563 | -90% |
|
|
HA
3
HHLR Advisors
Grand Cayman,
Cayman Islands
| $259K | 75,179 | -676,611 | -90% |
|
|
SCM
4
Superstring Capital Management
New York
| $106K | 30,792 | -277,128 | -90% |
|
5
Barclays
London,
United Kingdom
| $86K | 24,757 | -222,818 | -90% |
|
6
UBS Group
Zurich,
Switzerland
| $3.25K | 940 | -48,478 | -98% |
|
7
Fidelity International
Hamilton,
Bermuda
| – | – | -615,475 | Closed |
|
8
Bank of Montreal
Toronto,
Ontario, Canada
| – | – | -93,808 | Closed |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|